650 related articles for article (PubMed ID: 18573148)
1. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
[TBL] [Abstract][Full Text] [Related]
2. Oral health in patients on inhaled corticosteroid treatment.
Komerik N; Akkaya A; Yildiz M; Buyukkaplan US; Kuru L
Oral Dis; 2005 Sep; 11(5):303-8. PubMed ID: 16120117
[TBL] [Abstract][Full Text] [Related]
3. Influence of inhaled corticosteroids and dietary intake on bone density and metabolism in patients with moderate to severe asthma.
Gagnon L; Boulet LP; Brown J; Desrosiers T
J Am Diet Assoc; 1997 Dec; 97(12):1401-6. PubMed ID: 9404337
[TBL] [Abstract][Full Text] [Related]
4. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis.
Halpern MT; Schmier JK; Van Kerkhove MD; Watkins M; Kalberg CJ
Ann Allergy Asthma Immunol; 2004 Feb; 92(2):201-7; quiz 207-8, 267. PubMed ID: 14989387
[TBL] [Abstract][Full Text] [Related]
5. Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months.
Wang WQ; Ip MS; Tsang KW; Lam KS
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):445-50. PubMed ID: 9564795
[TBL] [Abstract][Full Text] [Related]
6. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
7. Should COPD patients be routinely evaluated for bone mineral density?
Karadag F; Cildag O; Yurekli Y; Gurgey O
J Bone Miner Metab; 2003; 21(4):242-6. PubMed ID: 12811630
[TBL] [Abstract][Full Text] [Related]
8. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
Harmanci E; Ak I; Ozdemir N; Vardareli E; Elbek O; Uçgun I
Allergol Immunopathol (Madr); 1999; 27(6):298-303. PubMed ID: 10611554
[TBL] [Abstract][Full Text] [Related]
9. Does addition of inhaled steroid to combined bronchodilator therapy affect health status in patients with COPD?
Yildiz F; Basyigit I; Yildirim E; Boyaci H; Ilgazli A
Respirology; 2004 Aug; 9(3):352-5. PubMed ID: 15363007
[TBL] [Abstract][Full Text] [Related]
10. Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy.
Malerba M; Bossoni S; Radaeli A; Mori E; Romanelli G; Tantucci C; Giustina A; Grassi V
Bone; 2006 Jan; 38(1):119-24. PubMed ID: 16154397
[TBL] [Abstract][Full Text] [Related]
11. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
12. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
Marcocci C; Golia F; Vignali E; Pinchera A
J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
[TBL] [Abstract][Full Text] [Related]
13. Inhaled corticosteroid-related tooth problems in asthmatics.
Han ER; Choi IS; Kim HK; Kang YW; Park JG; Lim JR; Seo JH; Choi JH
J Asthma; 2009 Mar; 46(2):160-4. PubMed ID: 19253123
[TBL] [Abstract][Full Text] [Related]
14. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid effects on proximal femur bone loss.
Sambrook P; Birmingham J; Kempler S; Kelly P; Eberl S; Pocock N; Yeates M; Eisman J
J Bone Miner Res; 1990 Dec; 5(12):1211-6. PubMed ID: 2075834
[TBL] [Abstract][Full Text] [Related]
16. The presence of emphysema does not affect the systemic bioactivity of inhaled fluticasone in severe chronic obstructive pulmonary disease.
Lee DK; Lipworth BJ
Br J Clin Pharmacol; 2004 Apr; 57(4):388-92. PubMed ID: 15025735
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-dose fluticasone propionate on bone density and metabolism in children with asthma.
Griffiths AL; Sim D; Strauss B; Rodda C; Armstrong D; Freezer N
Pediatr Pulmonol; 2004 Feb; 37(2):116-21. PubMed ID: 14730656
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
19. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
